V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270015935 | 270008175 | 1.87 | 80.5 | Curative (C) | 2015-06-14 | 2015-06-19 | BEACOPP-14 | 02 | N | 270012029 | BEACOPP |
| 270015936 | 270013888 | null | null | Adjuvant (A) | 2017-11-27 | 2018-01-31 | Trial Unspecified | null | null | 270012032 | TRIAL |
| 270015937 | 270008177 | 1.54 | 121.4 | Adjuvant (A) | 2016-04-28 | 2016-07-08 | CETUXIMAB | 02 | N | 270012041 | CETUXIMAB |
| 270015938 | 270013889 | null | 73.2 | Adjuvant (A) | 2016-01-18 | 2016-01-20 | HD EuroNet-PHL-C1 COPDAC | 02 | N | 270012055 | TRIAL |
| 270015939 | 270019586 | 1.85 | 89.5 | Curative (C) | 2013-05-30 | 2013-06-26 | Trial Unspecified | N | N | 270012061 | TRIAL |
| 270015940 | 270019586 | null | 78.4 | Curative (C) | 2016-01-15 | 2016-02-13 | COPP + Dacarbazine | 02 | N | 270012061 | COPP + DACARBAZINE |
| 270015941 | 270008180 | 1.65 | 83.7 | Palliative (P) | 2014-02-25 | 2014-04-28 | Trial Unspecified | 02 | null | 270012076 | TRIAL |
| 270015942 | 270008183 | 1.8 | 118.4 | Unknown (U) | null | 2015-08-05 | Escalated BEACOPP | N | N | 270012078 | BEACOPP |
| 270015943 | 270008184 | 1.84 | 51 | Palliative (P) | 2015-10-05 | 2016-08-30 | Cetuximab 14 day | N | N | 270012085 | CETUXIMAB |
| 270015944 | 270008185 | 1.72 | 107.5 | Adjuvant (A) | 2016-03-25 | 2016-06-11 | COPP + Dacarbazine | 02 | N | 270012088 | COPP + DACARBAZINE |
| 270015945 | 270008187 | 1.65 | 90.2 | Palliative (P) | 2015-11-10 | 2016-02-23 | COPP + Dacarbazine | N | N | 270012090 | COPP + DACARBAZINE |
| 270015946 | 270013896 | 1.78 | 90 | Palliative (P) | 2015-07-27 | 2016-02-18 | Cetuximab 14 day | N | N | 270012090 | CETUXIMAB |
| 270015947 | 270008191 | 1.76 | 78.4 | Adjuvant (A) | 2014-03-04 | 2014-04-30 | COPP + Dacarbazine | N | N | 270012098 | COPP + DACARBAZINE |
| 270015948 | 270008197 | 1.75 | 134 | null | 2015-01-31 | 2015-02-24 | CETUXIMAB | N | N | 270012115 | CETUXIMAB |
| 270015949 | 270008198 | 1.76 | 40.6 | null | 2014-09-11 | 2014-09-19 | Escalated BEACOPP | 02 | N | 270012118 | BEACOPP |
| 270015950 | 270008200 | 0 | 79.4 | null | null | 2013-12-22 | COPP + Dacarbazine | N | N | 270012125 | COPP + DACARBAZINE |
| 270015951 | 270008201 | 1.84 | 127 | Palliative (P) | 2015-03-15 | 2015-05-01 | CETUXIMAB | N | N | 270012130 | CETUXIMAB |
| 270015952 | 270013903 | 1.78 | 84.6 | Neo-adjuvant (N) | 2016-12-13 | 2016-12-20 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012137 | TRIAL |
| 270015953 | 270013904 | 0 | 59.6 | null | 2016-08-07 | 2016-08-07 | COPP + Dacarbazine | N | N | 270012138 | COPP + DACARBAZINE |
| 270015954 | 270008205 | 1.7 | 84 | Curative (C) | 2016-05-03 | 2016-05-16 | CETUXIMAB | N | N | 270012147 | CETUXIMAB |
| 270015955 | 270008207 | 1.77 | 53.6 | Curative (C) | 2017-04-10 | 2017-06-09 | Trial Unspecified | 2 | N | 270012148 | TRIAL |
| 270015956 | 270008207 | 1.76 | 99.4 | Curative (C) | 2015-08-08 | 2016-05-22 | CETUXIMAB | 2 | N | 270012148 | CETUXIMAB |
| 270015957 | 270008210 | 0 | 66.4 | Neo-adjuvant (N) | 2015-12-09 | 2016-02-07 | COPP + Dacarbazine | N | N | 270012172 | COPP + DACARBAZINE |
| 270015958 | 270008211 | null | 85 | Adjuvant (A) | 2014-11-29 | 2015-02-07 | Trial Unspecified | Y | N | 270012174 | TRIAL |
| 270015959 | 270008214 | 0 | 65 | Adjuvant (A) | 2014-03-27 | 2014-05-28 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012176 | TRIAL |
| 270015960 | 270008216 | null | 73.3 | Curative (C) | 2014-03-18 | 2014-05-27 | HD EuroNet-PHL-C1 COPDAC | N | null | 270012187 | TRIAL |
| 270015961 | 270008221 | null | 72.3 | Palliative (P) | 2017-04-19 | 2018-01-15 | Cetuximab 7 day (Cycle 1) | 99 | null | 270012193 | CETUXIMAB |
| 270015962 | 270008222 | 1.72 | 73 | Neo-adjuvant (N) | 2017-04-20 | 2017-12-08 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270012196 | CETUXIMAB |
| 270015963 | 270008225 | 1.74 | 51 | Curative (C) | 2014-04-26 | 2014-05-26 | Cetuximab 14 day | N | N | 270012199 | CETUXIMAB |
| 270015964 | 270013911 | 1.72 | 66.4 | Curative (C) | 2018-08-20 | 2018-08-20 | COPP + Dacarbazine | N | N | 270012205 | COPP + DACARBAZINE |
| 270015965 | 270008227 | 0 | 94.8 | Curative (C) | 2014-01-20 | 2014-01-20 | COPP + Dacarbazine | N | N | 270012207 | COPP + DACARBAZINE |
| 270015966 | 270008228 | 1.7 | 68.3 | null | 2018-06-21 | 2018-07-25 | CETUXIMAB | 2 | null | 270012217 | CETUXIMAB |
| 270015967 | 270008231 | 1.6 | 62 | Curative (C) | null | 2016-08-13 | COPP + Dacarbazine | N | N | 270012226 | COPP + DACARBAZINE |
| 270015968 | 270013914 | 1.79 | 81 | Curative (C) | 2014-05-25 | 2014-08-22 | Escalated BEACOPP | N | N | 270012227 | BEACOPP |
| 270015969 | 270008240 | 0 | 110.7 | Curative (C) | 2014-11-02 | 2014-11-06 | COPP + Dacarbazine | N | N | 270012246 | COPP + DACARBAZINE |
| 270015970 | 270008241 | 1.72 | 56.6 | Curative (C) | 2015-03-18 | 2015-03-19 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270012247 | TRIAL |
| 270015971 | 270008243 | null | 102.9 | Curative (C) | 2016-07-22 | 2016-09-17 | CETUXIMAB | N | N | 270012259 | CETUXIMAB |
| 270015972 | 270008246 | 0 | 89 | Curative (C) | 2014-05-12 | 2014-05-12 | COPP + Dacarbazine | N | null | 270012264 | COPP + DACARBAZINE |
| 270015973 | 270013918 | 1.67 | null | Disease modification (D) | 2018-02-28 | 2018-10-19 | Cetuximab 14 day | N | N | 270012265 | CETUXIMAB |
| 270015974 | 270013918 | 1.75 | 48 | Curative (C) | 2014-11-17 | 2014-11-24 | Cetuximab 14 day | 2 | N | 270012265 | CETUXIMAB |
| 270015975 | 270008251 | null | null | Curative (C) | 2014-04-12 | 2014-04-15 | COPP + Dacarbazine | 02 | N | 270012285 | COPP + DACARBAZINE |
| 270015976 | 270008254 | 1.75 | null | Neo-adjuvant (N) | 2013-08-02 | 2013-10-24 | CETUXIMAB | null | N | 270012289 | CETUXIMAB |
| 270015977 | 270008256 | 1.8 | 66 | Curative (C) | 2015-10-29 | 2015-11-02 | Trial Unspecified | 02 | N | 270012290 | TRIAL |
| 270015978 | 270008259 | 0 | null | Curative (C) | 2016-04-14 | 2016-04-15 | HD EuroNet-PHL-C1 COPDAC | 2 | null | 270012302 | TRIAL |
| 270015979 | 270008262 | 1.76 | 62 | Curative (C) | 2015-08-27 | 2015-10-24 | COPP + Dacarbazine | N | null | 270012303 | COPP + DACARBAZINE |
| 270015980 | 270008266 | 1.72 | 16.4 | Curative (C) | 2014-12-25 | 2014-12-27 | COPP + Dacarbazine | 02 | N | 270012310 | COPP + DACARBAZINE |
| 270015981 | 270008270 | 1.76 | 37.7 | Curative (C) | 2014-01-28 | 2014-02-11 | COPP + Dacarbazine | N | null | 270012323 | COPP + DACARBAZINE |
| 270015982 | 270008273 | null | 66.2 | Curative (C) | 2015-01-07 | 2015-01-11 | CETUXIMAB | 02 | N | 270012331 | CETUXIMAB |
| 270015983 | 270013926 | null | null | Curative (C) | 2014-01-31 | 2015-06-23 | Cetuximab 14 day | N | null | 270012334 | CETUXIMAB |
| 270015984 | 270008277 | 1.75 | 76.6 | Palliative (P) | null | 2013-08-01 | Trial Unspecified | null | N | 270012339 | TRIAL |